1. health and fitness

Haemodialysis is a treatment which is performed when kidney fails and it is no longer able to clean
the blood and remove excess fluid from the body. Haemodialysis catheters are used to exchange the
blood to and from the haemodialysis machine and patient. Life-saving haemodialysis treatments are
made possible through a vascular access. This access is created surgically through a vein which
allows blood flow during haemodialysis. A vascular access should be in place weeks or months
before the first haemodialysis treatment is done.
A tunnelled catheter is used for haemodialysis as it is placed under the skin. Haemodialysis is the
most common way to treat kidney failure. This treatment allows a person to lead a normal life
despite failing kidney. People who travel frequently and are on haemodialysis treatment, should
have the access of dialysis facilities beforehand. When kidney disease has progressed quickly
haemodialysis catheter is opted. Haemodialysis are recommended for people who cannot perform
peritoneal dialysis themselves. Central venous catheters are generally placed in a vein in the neck,
chest or groin. This type of catheter is not used for permanent access as it might get clogged or
become infected. PICC line is a catheter which is inserted into a vein in the arm. Tunnelled catheter
is inserted in a vein in the neck or chest passing under the skin.
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/11455
Haemodialysis Catheters Market: Drivers and Restraints
Increasing incidence of kidney disease, high blood pressure, heart attack, diabetes, Nephrotic
syndrome, drug abuse and autoimmune diseases are some of the main causes for kidney failure and
is expected to drive the haemodialysis catheter market over the forecast period. Moreover,
haemodialysis have many side effects such as low blood pressure, muscle cramps, sleep problems,
anaemia etc. These factors are expected to restrain the haemodialysis catheter market over the
forecast period.
Haemodialysis Catheters Market: Segmentation
Haemodialysis catheter market can be segmented on the basis of product type, end user and
geography.
Haemodialysis Catheters Market: Overview
Tunnelled catheters is expected to grow at a higher CAGR as tunnelled catheters are mostly used
for chronic haemodialysis and these catheters are not used for permanent access. Implanted port is
similar to that of tunnelled catheter, but is left entirely under the skin. Implanted sub-segment is
estimated to create good opportunity over the forecast period as implanted port requires very little
daily care than tunnelled catheter. In tunnelled catheters segment, tunnelled cuffed catheters subsegment is expected to grow at a faster rate as it can be used for longer than 3 weeks whereas, noncuffed tunnelled catheters are used for emergencies and for shorter duration.
Request To Sample of Report @ https://www.persistencemarketresearch.com/samples/11455
Haemodialysis Catheters Market: Region-wise Outlook
Region wise, the global haemodialysis catheter market is classified into countries namely, North
America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and
Africa. North America market is estimated to hold maximum revenue share globally, followed by
European market owing to increase in incidence of chronic disease such as diabetes, high blood
pressure, kidney failure etc.
Haemodialysis Catheters Market: Key Players
Some of the key players in haemodialysis catheter market includes C. R. Bard, Inc., Medtronic,
AngioDynamics, Amecath, CryoLife, Gambro, NIPRO Medical Corporation, Navilyst Medical,
Inc., Wesley Biotech Co., Ltd, Merit Medical Systems, Inc. and others.
Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/11455